BIIB - Biogen Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue12,273,90011,448,80010,763,8009,703,300
Cost of Revenue1,630,0001,426,3001,240,4001,171,000
Gross Profit10,643,90010,022,5009,523,4008,532,300
Operating Expenses
Research Development2,253,6001,973,3002,012,8001,893,400
Selling General and Administrative1,917,0001,947,9002,113,1002,232,300
Non Recurring----
Others----
Total Operating Expenses6,584,1005,720,9005,748,9005,735,600
Operating Income or Loss5,689,8005,727,9005,014,9003,967,700
Income from Continuing Operations
Total Other Income/Expenses Net-561,000-794,900-260,100-36,200
Earnings Before Interest and Taxes5,689,8005,727,9005,014,9003,967,700
Interest Expense-250,800-260,000-95,500-29,500
Income Before Tax5,128,8004,933,0004,754,8003,931,500
Income Tax Expense2,458,7001,237,3001,161,600989,900
Minority Interest-14,700-11,5002,1005,000
Net Income From Continuing Ops2,670,1003,695,7003,593,2002,941,600
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income2,539,1003,702,8003,547,0002,934,800
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares2,539,1003,702,8003,547,0002,934,800